Nils Anders Haegerstrand

This profile gathers the share dealings of Nils Anders Haegerstrand in Annexin Pharmaceuticals AB (publ). Between 7 January 2021 and 23 October 2024, the trades on record add up to 10 filings.

Purchases make up the whole of the open-market record (7 purchases, €93k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2024: 2 purchases and no sales on the market.

A typical purchase (the median) is worth €5,929. Of 7 purchases, 4 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The record was last updated on 24 October 2024 with an open-market purchase (€44k) in Annexin Pharmaceuticals AB (publ). The median gap between a trade and its publication by Finansinspektionen is 1 day. The regulation allows three business days to notify a trade (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.